The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019: what changed
262 changes of wording, as read on 19 Nov 2026.
The latest 200 of 262.
1
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 5 · Amendment of regulation 3 (scope of Regulations: special provisions)
199
- amended
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 4 · Definitions in relation to advanced therapy medicinal products
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 5 · Amendment of regulation 3 (scope of Regulations: special provisions)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 6 · Amendment of regulation 4 (special provision for pharmacies etc)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 7 · Amendment of regulation 5 (classification of medicinal products)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 8 · Amendment of Schedule 1 (further provisions for classification of medicinal products)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 10 · Amendment of regulation 8 (general interpretation)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 13 · New regulation B17 and C17 (good manufacturing practice and good distribution practice)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 14 · Amendment of regulation 17 (manufacturing of medicinal products)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 15 · Amendment of regulation 18 (wholesale dealing in medicinal products)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 16 · Insertion of new regulation 18A (approved country for import)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 17 · Amendment of regulation 19 (exemptions from requirement for wholesale dealer's licence)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 18 · Amendment of Schedule 3 (applications for licences under Part 3)
- new
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 19a · Amendment of regulation 24 (standard provisions of licences)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 20 · Amendment of Schedule 4 (standard provisions of licences under Part 3)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 21 · Amendment of regulation 26 (general power to suspend, revoke or vary licences)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 22 · Amendment of Schedule 5 (review upon oral representations)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 23 · Amendment of regulation 29 (variation of licence on the application of the holder)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 24 · Amendment of regulation 31 (certification of manufacturer's licence)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 25 · Amendment of regulation 33 (offence concerning data for advanced therapy medicinal products)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 26 · Amendment of Schedule 6 (manufacturer's and wholesale dealer's licences for exempt advanced therapy medicinal products)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 27 · Amendment of regulation 36 (conditions for manufacturer's licence)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 28 · Amendment of regulation 37 (manufacturing and assembly)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 29 · Amendment of regulation 38 (imports)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 30 · Amendment of regulation 39 (further requirements for manufacturer's licence)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 31 · Amendment of regulation 42 (conditions for wholesale dealer's licence)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 32 · Amendment of Schedule 7 (qualified persons)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 33 · Amendment of regulation 43 (obligations of licence holder)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 34 · Amendment of regulation 43A (requirement for wholesale dealers to decommission the unique identifier)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 35 · Amendment of regulation 44 (requirement for wholesale dealers to deal only with specified persons)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 36 · Amendment of regulation 45 (requirement as to responsible persons)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 37 · Insertion of new regulations 45AA and 45AB (responsible persons: import)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 38 · Amendment of regulation 45A (brokering in medicinal products)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 39 · Amendment of regulation 45D (grant or refusal of a broker's registration)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 40 · Amendment of regulation 45E (criteria of broker's registration)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 41 · Amendment of regulation 45F (provision of information)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 42 · Amendment of regulation 45M (criteria for importation, manufacture or distribution of an active substance)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 44 · Amendment of regulation 45O (requirements for registration as an importer, manufacturer or distributor of an active substance)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 45 · Amendment of regulation 46 (requirement for authorisation)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 46 · Amendment of regulation 47 (breach of requirement)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 47 · Amendment of regulation 48 (application of Part 5)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 48 · Amendment of regulation 49 (application for grant of UK marketing authorisation or parallel import licence)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 49 · Amendment of regulation 50 (accompanying material)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 50 · Amendment of Schedule 8 (material to accompany an application for a UK marketing authorisation)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 51 · Amendment of Schedule 8A (material to accompany an application for a parallel import licence)
- new
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 51a · Insertion of new Schedule 8C in relation to material to accompany unfettered access applications
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 52 · Amendment of Schedule 9 (undertakings by non-United Kingdom manufacturers)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 53 · New regulation 50A to 50J (applications in relation to particular medicinal products)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 55 · Amendment of Schedule 10 (national homoeopathic products)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 56 · Substitution of regulation 51 (applications relating to generic medicinal products)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 57 · Substitution of regulation 52 (applications relating to certain medicinal products that do not qualify as generic etc)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 58 · Substitution of regulation 53 (applications relating to similar biological medicinal products)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 59 · Amendment of regulation 54 (applications relating to products in well-established medicinal use)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 60 · Substitution of regulation 55 (applications relating to new combinations of active substances)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 62 · Amendment of regulation 58 (consideration of application)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 63 · Amendment of Schedule 11 (advice and representations)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 64 · Insertion of provisions concerning consideration of certain applications for UK marketing authorisations
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 65 · Amendment of regulation 59 (conditions of UK marketing authorisation or parallel import licence: general)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 66 · Amendment of regulation 60 (conditions of UK marketing authorisation: exceptional circumstances)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 67 · Insertion of new regulations 60A (condition as to the submitting of samples and other information to the appropriate authority) and 60B (submitting of samples and other information: EU marketing authorisations)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 68 · Amendment of regulation 61 (conditions of UK marketing authorisation)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 69 · Amendment of regulation 64 (duties of licensing authority in connection with determination)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 70 · Obligation of licensing authority in case of change of classification
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 72 · Validity of conditional marketing authorisation and variation of a UK marketing authorisation
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 74 · Amendment of regulation 66 (application for renewal of authorisation)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 75 · Amendment of regulation 66A (application for renewal of a parallel import licence)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 76 · Renewal of conditional marketing authorisation
- new
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 76a · Amendment of regulation 67 (failure to place on the market etc.)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 77 · Amendment of regulation 68 (revocation, variation and suspension of UK marketing authorisation or parallel import licence)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 78 · Amendment of regulation 69 (suspension of use etc of relevant medicinal product)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 80 · Amendment of regulation 71 (withdrawal of medicinal product from the market)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 81 · Amendment of regulation 72 (sale etc of suspended medicinal product)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 82 · Amendment of regulation 73 (obligation to notify placing on the market etc)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 83 · Amendment of regulation 75 (obligation to provide information relating to safety etc)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 84 · Amendment of regulation 76 (obligation in relation to product information)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 87 · Post authorisation requirements in relation to UK marketing authorisations with paediatric aspects and advanced therapy medicinal products
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 88 · Amendment of regulation 79 (failure to provide information on marketing authorisations to EMA)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 89 · Amendment of regulation 80 (urgent safety restrictions)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 90 · Application of regulations 81 to 94 (offences relating to EU marketing authorisations)
- new
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 90a · Amendment of regulation 89 (offences in connection with withdrawal of product from market)
- new
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 90b · Omission of regulation 91 (failure to notify results of third country clinical trials)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 91 · Amendment of regulation 94A (offences relating to Commission Regulation 2016/161)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 92 · Amendment of regulation 95 (offences in connection with application)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 94 · Amendment of regulation 97 (breach of pharmacovigilance condition)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 98 · Amendment of regulation 102 (regulation-making power to amend regulation 102(4) to (6))
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 99 · Amendment of regulation 103 (application for certificate of registration)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 100 · Amendment of regulation 104 (consideration of application)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 101 · Amendment of regulation 108 (application for renewal of certificate)
- new
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 101a · Amendment of regulation 109 (failure to place on the market etc.)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 102 · Amendment of regulation 110 (revocation, variation and suspension of certificate of registration)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 105 · Amendment of regulation 113 (obligation to notify placing on the market etc)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 106 · Amendment of regulation 115 (obligation to provide information relating to safety etc)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 107 · Amendment of regulation 116 (obligation in relation to product information)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 108 · Amendment of italic heading above regulation 125 (traditional herbal medicinal products)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 109 · Insertion of regulation 124A (interpretation)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 110 · Amendment of regulation 125 (traditional herbal medicinal products)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 111 · Insertion of regulation 125A (list of approved countries for herbal medicinal products)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 112 · Insertion of new italic heading and regulation 126A (list of herbal substances, preparations and combinations for use in traditional herbal medicinal products)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 113 · Amendment of regulation 127 (application for grant of traditional herbal registration)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 114 · Amendment of regulation 128 (accompanying material)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 115 · Amendment of Schedule 12 (material to accompany an application for a traditional herbal registration)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 116 · Amendment of regulation 130 (consideration of application)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 117 · Insertion of regulation 130A (procedure where less than 15 years use of traditional herbal medicinal product)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 118 · Amendment of regulation 133 (application for renewal of registration)
- new
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 118a · Amendment of regulation 134 (failure to place on the market etc.)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 119 · Amendment of regulation 135 (revocation, variation and suspension of traditional herbal registration)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 120 · Amendment of regulation 136 (revocation by licensing authority: further provisions)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 123 · Amendment of regulation 140 (withdrawal of traditional herbal medicinal product from the market)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 125 · Amendment of regulation 142 (obligation to notify placing on the market etc)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 126 · Insertion of new regulation 143A (establishment of herbal monographs)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 127 · Substitution of regulation 144 (obligation following new herbal monograph)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 128 · Amendment of regulation 145 (obligation to provide information relating to safety etc)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 129 · Amendment of regulation 146 (obligation in relation to product information)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 130 · Insertion of regulation 148A (urgent safety restrictions)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 131 · Substitution of regulation 149 (urgent safety restrictions)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 132 · Amendment of regulation 156 (article 126a authorisations)
- new
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 132a · Amendment of regulation 157 (requests from other member States)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 133 · Amendment of regulation 159 (provisional determination)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 134 · Amendment of regulation 164 (effect of determination)
- new
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 135za · New regulation 135ZA (amendment of regulation 167 (supply to fulfil special patient needs))
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 135 · Amendment of regulation 168 (use of non-prescription medicines in the course of a business)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 136 · Amendment of regulation 169 (mixing of general sale medicinal products)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 137 · Amendment of regulation 171 (exempt advanced therapy medicinal products)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 138 · Amendment of regulation 173 (exemption for certain radiopharmaceuticals)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 139 · Amendment of regulation 177 (application of Part and interpretation)
- new
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 139a · Amendment of regulation 179 (obligation on licensing authority to operate pharmacovigilance system)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 140 · Amendment of regulation 180 (obligation on licensing authority to audit pharmacovigilance system)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 141 · Amendment of regulation 181 (delegation of obligations under Part 11)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 142 · Amendment of regulation 182 (obligation on holder to operate a pharmacovigilance system)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 143 · Amendment of regulation 184 (obligation on holder to audit pharmacovigilance system)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 144 · Amendment of regulation 185 (recording obligations on the licensing authority)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 145 · Amendment of regulation 186 (reporting obligations on the licensing authority)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 146 · Insertion of new regulation 187A (collaboration with the World Health Organisation)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 147 · Amendment of regulation 187 (recording obligations on holders)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 148 · Amendment of regulation 188 (reporting obligations on holders)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 149 · Amendment of regulation 189 (signal detection: licensing authority obligations)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 150 · Amendment of regulation 190 (signal detection: holder obligation)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 151 · Amendment of regulation 191 (obligation on holder to submit periodic safety update reports: general requirements)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 152 · Amendment of regulation 192 (obligation to submit periodic safety reports: derogation from general requirements)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 153 · Amendment of regulation 193 (harmonisation of PSUR frequency or date of submission)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 154 · Amendment of regulation 194 (responding to a single assessment of PSUR under Article 107e of the 2001 Directive)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 155 · Amendment of regulation 195 (obligation on licensing authority to assess PSURs)
- new
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 156za · Amendment of regulation 196 (urgent action)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 156 · Insertion of new regulation 196A (major safety review by the licensing authority)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 157 · Amendment of regulation 197 (EU urgent action procedure)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 158 · Amendment of regulation 198 (post-authorisation safety studies: general provisions)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 159 · Amendment of regulation 199 (submission of draft study protocols for required studies)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 160 · Amendment of regulation 200 (amendment to study protocols for required studies)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 161 · Amendment of regulation 201 (submission and evaluation of final study reports for required studies)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 162 · Amendment of regulation 202 (follow up of final study reports)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 163 · Insertion of new regulation 202A (medicinal products subject to additional monitoring)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 164 · Amendment of regulation 203 (obligations on licensing authority in relation to national medicines web-portal)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 165 · Amendment of regulation 204 (obligation on licensing authority in relation to public announcements)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 166 · Amendment of regulation 205 (obligations on holders in relation to public announcements)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 167 · Insertion of regulation 205A (further obligations in respect of pharmacovigilance activities)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 169 · Insertion of regulation 205B (guidance in respect of good pharmacovigilance practice and post authorisation efficacy studies)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 170 · Amendment of regulation 206 (infringement notices)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 171 · Amendment of regulation 207 (offences)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 175 · Amendment of regulation 210A (offences in relation to pharmacovigilance obligations under the Implementing Regulation)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 177 · Amendment of regulation 212 (transitional arrangements)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 178 · Amendment of Schedule 33 (transitional arrangements: pharmacovigilance)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 179 · Amendment of regulation 213 (interpretation of Part 12)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 180 · Amendment of regulation 214 (sale or supply of prescription only medicines)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 181 · Amendment of regulation 216 (exceptions to regulation 215)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 182 · Amendment of regulation 217 (requirements for prescriptions: general)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 184 · Amendment of regulation 218 (requirements for prescriptions: EEA health professionals)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 185 · Amendment of regulation 219 (electronic prescriptions)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 186 · Amendment of regulation 219A (electronic prescriptions: EEA health professionals)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 187 · Amendment of regulation 229 (exemption for supply by national health services bodies and local authorities)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 188 · Amendment of regulation 230 (exemption for supply etc under a PGD to assist doctors or dentists)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 189 · Amendment of regulation 231 (exemption for supply etc under a PGD by independent hospitals etc.)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 190 · Amendment of regulation 232 (exemption for supply etc under a PGD by dental practices and clinics: England and Wales)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 191 · Amendment of regulation 233 (exemption for supply etc under a PGD by a person conducting a retail pharmacy business)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 192 · Amendment of regulation 234 (exemption for supply etc of products under a PGD to assist the police etc)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 193 · Amendment of Schedule 17 (exemptions for sale, supply or administration by certain persons)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 194 · Amendment of regulation 249 (restrictions on persons to be supplied with medicinal products)
- new
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 194a · Amendment of regulation 251 (compliance with standards specified in certain publications)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 195 · Amendment of regulation 254 (prohibitions concerning traceability of treatment with advanced therapy medicinal products)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 196 · Amendment of regulation 255B (exception to Article 25 of Commission Regulation 2016/161: health care institutions)
- new
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 196a · Amendment of regulation 255B (exception to Article 25 of Commission Regulation 2016/161: health care institutions)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 197 · Amendment of Part 12A
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 198 · Amendment of regulation 257 (packaging requirements: general)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 199 · Amendment of regulation 257A (packaging requirements: medicinal products required to bear safety features)
- new
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 199a · Amendment of regulation 257B (transitional arrangements)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 200 · Insertion of regulations 257C (packaging requirements: advanced therapy medicinal products) and 257D and 257E (guidance and regulations in relation to packing, leaflets and labelling)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 201 · Amendment of Schedule 24 (packaging information requirements)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 202 · Amendment of regulation 259 (packaging requirements: information for blind and partially sighted patients)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 203 · Amendment of regulation 260 (package leaflets)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 204 · Amendment of Schedule 27 (package leaflets)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 206 · Amendment of regulation 267 (submission of mock-ups of packaging and leaflets to licensing authority)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 207 · Amendment of regulation 268 (offence relating to packaging and package leaflets)
- new
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 207a · Insertion of new regulation 268A (offence relating to packaging and package leaflets in Northern Ireland: holder of authorisation etc)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 208 · Amendment of regulation 269 (offences relating to packaging and package leaflets: other persons)
- new
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 208a · Insertion of new regulation 269A (offences relating to packaging and package leaflets in Northern Ireland: other persons)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 209 · Amendment of regulation 270 (non-compliance with requirements of this Part)
- new
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 209a · Amendment of regulation 271 (offences: penalties)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 211 · Amendment of regulation 279 (products without a marketing authorisation)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 212 · Amendment of regulation 280 (general principles)
- amended
Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, 213 · Amendment of regulation 281 (duties of authorisation holders and registration holders)